Urogen Pharma Financial Overview
Urogen Pharma's market cap is currently $1.10B. The company's EPS TTM is $-0.69; its P/E ratio is -6.76; Urogen Pharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
